The local medical landscape is abuzz with the emergence of retatrutide, a novel dual GIP and GLP-1 medication showing significant results in scientific trials for managing obesity. This medication https://indexedbookmarks.com/story21677476/the-new-retatrutide-australia-a-emerging-hope-for-obesity-treatment